Search
for
Sort by
Research 241–270 of 1000+
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- New and Emerging Therapies for Alopecia Areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Helicobacter pylori infection and skin disorders
- Common Dermatologic Disorders in Down Syndrome: Systematic Review
- Evaluation of serum levels of IL-6, IL-10, and TNF-a in alopecia areata patients: A systematic review and meta-analysis
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study
- Janus Kinase inhibitors in dermatology: a review
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Understanding autoimmunity of vitiligo and alopecia areata
- Stress-related skin disorders
- Regulatory T cells in inflammatory skin disease: from mice to humans
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- METHOTREXATE FOR GENERALIZED PUSTULAR PSORIASIS IN A 2-YEAR-OLD CHILD
- Yellow and orange in cutaneous lesions: clinical and dermoscopic data
- Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- Novel drugs of United States Food and Drug Administration approved in 2024
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases